Tongue cancer pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 7: Line 7:
==Pathophysiology==
==Pathophysiology==
===Genetics===
===Genetics===
The [[mutations]] in [[tumor suppressor genes]] has been reported in patients with tongue cancer. Genes involved in the pathogenesis of tongue cancer include ''[[TP53]]'', which is located on [[chromosome 17]]. Other oncogenes associated with [[squamous cell cancers]] of the tongue include ''[[c-myc]]'' and ''erb -b1''.
The [[mutations]] in [[tumor suppressor genes]] has been reported in patients with tongue cancer. Genes involved in the pathogenesis of tongue cancer include ''[[TP53]]'', which is located on [[chromosome 17]]. Other oncogenes associated with squamous cell cancers of the tongue include ''[[c-myc]]'' and ''erb -b1''.
===Gross pathology===
===Gross pathology===
[[Squamous cell carcinoma]] is  the most common malignancy of the tongue. It typically has three gross morphologic growth patterns: exophytic, ulcerative, and infiltrative.
[[Squamous cell carcinoma]] is  the most common malignancy of the tongue. It typically has three gross morphologic growth patterns: exophytic, ulcerative, and infiltrative.

Revision as of 21:48, 2 December 2015

Tongue cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tongue cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tongue cancer pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tongue cancer pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tongue cancer pathophysiology

CDC on Tongue cancer pathophysiology

Tongue cancer pathophysiology in the news

Blogs on Tongue cancer pathophysiology

Directions to Hospitals Treating Tongue cancer

Risk calculators and risk factors for Tongue cancer pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

Genes involved in the pathogenesis of tongue cancer include TP53, c-myc, and erb-b1. On gross pathology, exophytic, ulcerative, and infiltarative growth patterns are characteristic findings of tongue cancer.

Pathophysiology

Genetics

The mutations in tumor suppressor genes has been reported in patients with tongue cancer. Genes involved in the pathogenesis of tongue cancer include TP53, which is located on chromosome 17. Other oncogenes associated with squamous cell cancers of the tongue include c-myc and erb -b1.

Gross pathology

Squamous cell carcinoma is the most common malignancy of the tongue. It typically has three gross morphologic growth patterns: exophytic, ulcerative, and infiltrative. The infiltrative and ulcerative are the types most commonly observed on the tongue.The macroscopic appearance of tongue cancer depends on the following:

A fully developed tongue lesion appears as an exophytic bulky lesion that is gray to grayish-red and has a rough, shaggy, or papillomatous surface.

Microscopic Pathology

  • Microscopically, tongue cancers are broadly based and invasive through papillary fronds.
  • Tongue cancer constitutes of highly differentiated squamous cells lacking frank cytologic criteria of malignancy with rare mitoses. The surface of the lesion is covered with compressed invaginating folds of keratin layers. An astromalike inflammatory reaction and a blunt pushing margin may be seen.

Pathogenesis

  • Leukoplakia and erythroplakia have the greatest potential for malignant transformation in tongue cancer. Leukoplakia is defined as a white patch of the mucosa that cannot be characterized clinically or pathologically as any other disease.
  • Leukoplakia is considered a premalignant condition from the chronic irritation of the mucous membranes, resulting in increased rates of epithelial and connective tissue proliferation.
  • Leukoplakia usually occurs after the age of 40 years, with the peak incidence before age 50 years. Leukoplakia is 2-3 times more common in men than in women.
  • The rates of malignant transformation of leukoplakic lesions range from less than 1% to as high as 17.5%, averaging 4.5-6%. Erythroleukoplakia (leukoplakia erosiva) and nodular leukoplakia exhibit the highest rate of malignant transformation.
  • Erythroplakia is defined as a red, velvety plaque found on the oral mucosa that cannot be ascribed to any other predetermined condition. No sex predilection is recognized in erythroplakia and it is rarely found on the tongue compared with other sites in the oral cavity. Erothroplakia is considered as the earliest sign of asymptomatic cancer by Mashberg.[1]

The two most common types of pre-cancerous conditions on the tongue are called leukoplakia and erythroplakia and they can usually be easily spotted by a dentist or dental hygienist. While these spots start off harmless and do not initially spread to any other part of the body, they exhibit characteristics that could develop into cancer. Leukoplakia is usually a white or grayish patch and erythroplakia is a red patch. According to the American Cancer Society about 1 out of every 5 cases of leukoplakia is cancerous or will develop into cancer if not treated. Erythroplakia is less common, but more serious. The majority of found erythroplakia cases are cancerous or will develop into it. After having pre-cancerous spots removed it is important that you have regular check ups with a dentist or doctor to monitor your tongue and check for a recurrence of pre-cancerous spots.

References

  1. A. Mashberg (1978). "Erythroplasia: the earliest sign of asymptomatic oral cancer". Journal of the American Dental Association (1939). 96 (4): 615–620. PMID 0273632. Unknown parameter |month= ignored (help)